标题
Tackling breast cancer chemoresistance with nano-formulated siRNA
作者
关键词
-
出版物
GENE THERAPY
Volume 23, Issue 12, Pages 821-828
出版商
Springer Nature
发表日期
2016-09-20
DOI
10.1038/gt.2016.67
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Co-delivery of Se nanoparticles and pooled SiRNAs for overcoming drug resistance mediated by P-glycoprotein and class III β-tubulin in drug-resistant breast cancers
- (2016) Wenjing Zheng et al. Acta Biomaterialia
- Recent progress in development of siRNA delivery vehicles for cancer therapy
- (2016) Hyun Jin Kim et al. ADVANCED DRUG DELIVERY REVIEWS
- Dual antitumoral potency of EG5 siRNA nanoplexes armed with cytotoxic bifunctional glutamyl-methotrexate targeting ligand
- (2016) Dian-Jang Lee et al. BIOMATERIALS
- Reversing of multidrug resistance breast cancer by co-delivery of P-gp siRNA and doxorubicin via folic acid-modified core-shell nanomicelles
- (2016) Yang Wu et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- Therapeutic potential of targeted multifunctional nanocomplex co-delivery of siRNA and low-dose doxorubicin in breast cancer
- (2015) Dawen Dong et al. CANCER LETTERS
- Cancer-targeted MDR-1 siRNA delivery using self-cross-linked glycol chitosan nanoparticles to overcome drug resistance
- (2015) Ji Young Yhee et al. JOURNAL OF CONTROLLED RELEASE
- PEGylated Hyaluronic Acid-Modified Liposomal Delivery System with Anti-γ-Glutamylcyclotransferase siRNA for Drug-Resistant MCF-7 Breast Cancer Therapy
- (2015) Rui Ran et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Overcoming Akt Induced Therapeutic Resistance in Breast Cancer through siRNA and Thymoquinone Encapsulated Multilamellar Gold Niosomes
- (2015) Shashi Rajput et al. MOLECULAR PHARMACEUTICS
- Lipid Nanocarriers of a Lipid-Conjugated Estrogenic Derivative Inhibit Tumor Growth and Enhance Cisplatin Activity against Triple-Negative Breast Cancer: Pharmacokinetic and Efficacy Evaluation
- (2015) Terrick Andey et al. MOLECULAR PHARMACEUTICS
- Knocking down disease: a progress report on siRNA therapeutics
- (2015) Anders Wittrup et al. NATURE REVIEWS GENETICS
- Silencing of Bcl-2 expression by small interfering RNA induces autophagic cell death in MCF-7 breast cancer cells
- (2014) Ugur Akar et al. Autophagy
- Delivery of siRNA by MRI-visible nanovehicles to overcome drug resistance in MCF-7/ADR human breast cancer cells
- (2014) Gan Lin et al. BIOMATERIALS
- Co-delivery of doxorubicin and RNA using pH-sensitive poly (β-amino ester) nanoparticles for reversal of multidrug resistance of breast cancer
- (2014) Shan Tang et al. BIOMATERIALS
- Nano carriers that enable co-delivery of chemotherapy and RNAi agents for treatment of drug-resistant cancers
- (2014) Vasilios Tsouris et al. BIOTECHNOLOGY ADVANCES
- Phospholipid-modified PEI-based nanocarriers for in vivo siRNA therapeutics against multidrug-resistant tumors
- (2014) S Essex et al. GENE THERAPY
- Nanocarrier mediated delivery of siRNA/miRNA in combination with chemotherapeutic agents for cancer therapy: Current progress and advances
- (2014) Nishant S. Gandhi et al. JOURNAL OF CONTROLLED RELEASE
- Transferrin Receptor-Mediated Endocytosis: A Useful Target for Cancer Therapy
- (2014) Stephanie Tortorella et al. JOURNAL OF MEMBRANE BIOLOGY
- Hydrogel Doped with Nanoparticles for Local Sustained Release of siRNA in Breast Cancer
- (2014) Nathaly Segovia et al. Advanced Healthcare Materials
- NFκB mediates cisplatin resistance through histone modifications in head and neck squamous cell carcinoma (HNSCC)
- (2014) Luciana O. Almeida et al. FEBS Open Bio
- KIF14 Promotes AKT Phosphorylation and Contributes to Chemoresistance in Triple-Negative Breast Cancer
- (2014) Stina M. Singel et al. NEOPLASIA
- Codelivery of an Optimal Drug/siRNA Combination Using Mesoporous Silica Nanoparticles To Overcome Drug Resistance in Breast Cancer in Vitro and in Vivo
- (2013) Huan Meng et al. ACS Nano
- Layer-by-Layer Nanoparticles for Systemic Codelivery of an Anticancer Drug and siRNA for Potential Triple-Negative Breast Cancer Treatment
- (2013) Zhou J. Deng et al. ACS Nano
- Codelivery of mTERT siRNA and paclitaxel by chitosan-based nanoparticles promoted synergistic tumor suppression
- (2013) Wei Wei et al. BIOMATERIALS
- Polypeptide cationic micelles mediated co-delivery of docetaxel and siRNA for synergistic tumor therapy
- (2013) Cuifang Zheng et al. BIOMATERIALS
- Rigid nanoparticle-based delivery of anti-cancer siRNA: Challenges and opportunities
- (2013) Zhiyong Wang et al. BIOTECHNOLOGY ADVANCES
- Polymeric micelles containing reversibly phospholipid-modified anti-survivin siRNA: A promising strategy to overcome drug resistance in cancer
- (2013) G. Salzano et al. CANCER LETTERS
- Targeting histone modifications—epigenetics in cancer
- (2013) Tanja Waldmann et al. CURRENT OPINION IN CELL BIOLOGY
- Effective response of doxorubicin-sensitive and -resistant breast cancer cells to combinational siRNA therapy
- (2013) Hamidreza Montazeri Aliabadi et al. JOURNAL OF CONTROLLED RELEASE
- Chromatin Modifications Sequentially Enhance ErbB2 Expression in ErbB2-Positive Breast Cancers
- (2013) Sathish Kumar Mungamuri et al. Cell Reports
- Exploring Polymeric Micelles for Improved Delivery of Anticancer Agents: Recent Developments in Preclinical Studies
- (2013) Chalet Tan et al. Pharmaceutics
- Lipid modified triblock PAMAM-based nanocarriers for siRNA drug co-delivery
- (2012) Swati Biswas et al. BIOMATERIALS
- Cancer Epigenetics: From Mechanism to Therapy
- (2012) Mark A. Dawson et al. CELL
- Cell-penetrating peptide mimicking polymer-based combined delivery of paclitaxel and siRNA for enhanced tumor growth suppression
- (2012) Yeon Lim Jang et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Anti-Her2 single-chain antibody mediated DNMTs-siRNA delivery for targeted breast cancer therapy
- (2012) Shuang Dou et al. JOURNAL OF CONTROLLED RELEASE
- Action and Reaction: The Biological Response to siRNA and Its Delivery Vehicles
- (2012) Rosemary L Kanasty et al. MOLECULAR THERAPY
- Co-delivery of siRNA and therapeutic agents using nanocarriers to overcome cancer resistance
- (2012) Mar Creixell et al. Nano Today
- Enhancement of chemotherapeutic efficacy in hypermethylator breast cancer cells through targeted and pharmacologic inhibition of DNMT3b
- (2011) Rupninder Sandhu et al. BREAST CANCER RESEARCH AND TREATMENT
- Cationic solid lipid nanoparticles for co-delivery of paclitaxel and siRNA
- (2011) Yong Hee Yu et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Peptides in cancer nanomedicine: Drug carriers, targeting ligands and protease substrates
- (2011) Xiao-Xiang Zhang et al. JOURNAL OF CONTROLLED RELEASE
- Recent attempts at RNAi-mediated P-glycoprotein downregulation for reversal of multidrug resistance in cancer
- (2011) Meysam Abbasi et al. MEDICINAL RESEARCH REVIEWS
- A Double-modulation Strategy in Cancer Treatment With a Chemotherapeutic Agent and siRNA
- (2011) Kazuya Nakamura et al. MOLECULAR THERAPY
- P-glycoprotein silencing with siRNA delivered by DOPE-modified PEI overcomes doxorubicin resistance in breast cancer cells
- (2011) Gemma Navarro et al. Nanomedicine
- Cationic Liposomal Co-delivery of Small Interfering RNA and a MEK Inhibitor for Enhanced Anticancer Efficacy
- (2011) Seung Hee Kang et al. PHARMACEUTICAL RESEARCH
- Delivery of siRNA Therapeutics: Barriers and Carriers
- (2010) Jie Wang et al. AAPS Journal
- Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles
- (2010) Chunbai He et al. BIOMATERIALS
- The synergistic effect of hierarchical assemblies of siRNA and chemotherapeutic drugs co-delivered into hepatic cancer cells
- (2010) Nuo Cao et al. BIOMATERIALS
- Reversal of multidrug resistance by small interfering RNA (siRNA) in doxorubicin-resistant MCF-7 breast cancer cells
- (2010) Yaprak Dönmez et al. BIOMEDICINE & PHARMACOTHERAPY
- Sequential treatment of drug-resistant tumors with RGD-modified liposomes containing siRNA or doxorubicin
- (2010) Juan Jiang et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Multifunctional Nanoparticles Delivering Small Interfering RNA and Doxorubicin Overcome Drug Resistance in Cancer
- (2010) Yunching Chen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Antibody fragments
- (2010) Aaron L. Nelson mAbs
- Nanoparticles Targeted With NGR Motif Deliver c-myc siRNA and Doxorubicin for Anticancer Therapy
- (2010) Yunching Chen et al. MOLECULAR THERAPY
- Nanoparticles Modified With Tumor-targeting scFv Deliver siRNA and miRNA for Cancer Therapy
- (2010) Yunching Chen et al. MOLECULAR THERAPY
- Nanotechnology-Based Cancer Therapeutics—Promise and Challenge—Lessons Learned Through the NCI Alliance for Nanotechnology in Cancer
- (2010) Dorothy Farrell et al. PHARMACEUTICAL RESEARCH
- Lipid-based systemic delivery of siRNA
- (2009) Yu-Cheng Tseng et al. ADVANCED DRUG DELIVERY REVIEWS
- Involvement of miR-326 in chemotherapy resistance of breast cancer through modulating expression of multidrug resistance-associated protein 1
- (2009) Zhongxing Liang et al. BIOCHEMICAL PHARMACOLOGY
- The use of nanoparticle-mediated targeted gene silencing and drug delivery to overcome tumor drug resistance
- (2009) Yogesh B. Patil et al. BIOMATERIALS
- Co-delivery of siRNA and paclitaxel into cancer cells by biodegradable cationic micelles based on PDMAEMA–PCL–PDMAEMA triblock copolymers
- (2009) Caihong Zhu et al. BIOMATERIALS
- Single-step doxorubicin-selected cancer cells overexpress the ABCG2 drug transporter through epigenetic changes
- (2008) A M Calcagno et al. BRITISH JOURNAL OF CANCER
- A new mechanism of drug resistance in breast cancer cells: fatty acid synthase overexpression-mediated palmitate overproduction
- (2008) H. Liu et al. MOLECULAR CANCER THERAPEUTICS
- Nanoparticle-mediated cellular response is size-dependent
- (2008) Wen Jiang et al. Nature Nanotechnology
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now